In recent years, anti-PD‐1/PD‐L1 therapy has shown promising clinical prospects in the treatment of thyroid carcinomas, including papillary thyroid carcinoma (PTC) and MTC. Here, CD274 is linked to medullary thyroid gland carcinoma.